References
- Zimmet, P., Alberti, K. G. and Shaw, J. (2001) Global and societal implications of the diabetes epidemic. Nature 414: 782-787. https://doi.org/10.1038/414782a
- King, H., Aubert, R. E. and Herman, W. H. (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414-1431. https://doi.org/10.2337/diacare.21.9.1414
- Moller, D. E. (2001) New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414: 821-827. https://doi.org/10.1038/414821a
- Koren, S. and Fantus, I. G. (2007) Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus. Best Pract. Res. Clin. Endocrinol. Metab. 21: 621-640. https://doi.org/10.1016/j.beem.2007.08.004
- Bleyle, L. A., Peng, Y., Ellis, C. and Mooney, R. A. (1999) Dissociation of PTPase levels from their modulation of insulin receptor signal transduction. Cell Signal. 11: 719-725. https://doi.org/10.1016/S0898-6568(99)00043-1
- Cheng, A., Dubé, N., Gu, F. and Tremblay, M. L. (2002) Coordinated action of protein tyrosine phosphatases in insulin signal transduction. Eur. J. Biochem. 269: 1050-1059. https://doi.org/10.1046/j.0014-2956.2002.02756.x
- Goldstein, B. J., Ahmad, F., Ding, W., Li, P. M. and Zhang, W. R. (1998) Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases. Mol. Cell. Biochem. 182: 91-99. https://doi.org/10.1023/A:1006812218502
- Johnson, T. O., Ermolieff, J. and Jirousek, M. R. (2002) Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat. Rev. Drug Discov. 1: 696-709. https://doi.org/10.1038/nrd895
- Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms- Hagen, J., Chan, C. C., Ramachandran, C., Gresser, M. J., Tremblay, M. L. and Kennedy, B. P. (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase 1B gene. Science 283: 1544-1548. https://doi.org/10.1126/science.283.5407.1544
- Klaman, L. D., Boss, O., Peroni, O. D., Kim, J. K., Martino, J. L., Zabolotny, J. M., Moghal, N., Lubkin, M., Kim, Y. B., Sharpe, A. H., Stricker-Krongrad, A., Shulman, G. I., Neel, B. G. and Kahn, B. B. (2000) Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice. Mol. Cell Biol. 20: 5479-5489. https://doi.org/10.1128/MCB.20.15.5479-5489.2000
- Zabolotny, J. M., Bence-Hanulec, K. K., Stricker-Krongrad, A., Haj, F., Wang, Y., Minokoshi, Y., Kim, Y. B., Elmquist, J. K., Tartaglia, L. A., Kahn, B. B. and Neel, B. G. (2002) PTP1B regulates leptin signal transduction in vivo. Dev. Cell 2: 489-495. https://doi.org/10.1016/S1534-5807(02)00148-X
- Zinker, B. A., Rondinone, C. M., Trevillyan, J. M., Gum, R. J., Clampit, J. E., Waring, J. F., Xie, N., Wilcox, D., Jacobson, P., Frost, L., Kroeger, P. E., Reilly, R. M., Koterski, S., Opgenorth, T. J., Ulrich, R. G., Crosby, S., Butler, M., Murray, S. F., McKay, R. A., Bhanot, S., Monia, B. P. and Jirousek, M. R. (2002) PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc. Natl. Acad. Sci. USA 99: 11357-11362. https://doi.org/10.1073/pnas.142298199
- Gum, R. J., Gaede, L. L., Koterski, S. L., Heindel, M., Clampit, J. E., Zinker, B. A., Trevillyan, J. M., Ulrich, R. G., Jirousek, M. R. and Rondinone, C. M. (2003) Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes 52: 21-28. https://doi.org/10.2337/diabetes.52.1.21
- Zhang, Y. N., Zhang, W., Hong, D., Shi, L., Shen, Q., Li, J. Y., Li, J. and Hu, L. H. (2008) Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities. Bioorg. Med. Chem. 16: 8697-8705. https://doi.org/10.1016/j.bmc.2008.07.080
- Cui, L., Na, M., Oh, H., Bae, E. Y., Jeong, D. G., Ryu, S. E., Kim, S., Kim, B. Y., Oh, W. K. and Ahn, J. S. (2006) Protein tyrosine phosphatase 1B inhibitors from Morus root bark. Bioorg. Med. Chem. Lett. 16: 1426-1429. https://doi.org/10.1016/j.bmcl.2005.11.071
- Erbe, D. V., Klaman, L. D., Wilson, D. P., Wan, Z. K., Kirincich, S. J., Will, S., Xu, X., Kung, L., Wang, S., Tam, S., Lee, J. and Tobin, J. F. (2009) Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling. Diabetes Obes. Metab. 11: 579-588. https://doi.org/10.1111/j.1463-1326.2008.01022.x
-
Hung, T. M., Hoang, D. M., Minh, P. T. H., Youn, U. J., Na, M. K., Oh, W. K., Min, B. S. and Bae, K. (2007)
$\alpha$ -Amylase and protein tyrosine phosphatase 1B inhibitory of some Vietnamese medicinal plants used to treat diabetes. Natural Product Sciences 13: 311-316. - Hung, T. M., Hoang, D. M., Kim, J. C., Jang, H. S., Ahn, J. S. and Min, B. S. (2009) Protein tyrosine phosphatase 1B inhibitory by dammaranes from Vietnamese Giao-Co-Lam tea. J. Ethnopharmacol. 124: 240-245 https://doi.org/10.1016/j.jep.2009.04.027
- Lee, H. J., Kim, Y. A., Lee, J. I., Lee, B. J. and Seo, Y. (2007) Screening of Korean marine plants extracts for inhibitory activity on protein tyrosine phosphatase 1B. J. Appl. Biol. Chem. 50: 74-77.
- Seo, C., Sohn, J. H., Ahn, J. S., Yim, J. H., Lee, H. K. and Oh, H. (2009) Protein tyrosine phosphatase 1B inhibitory effects of depsidone and pseudodepsidone metabolites from the Antarctic lichen Stereocaulon alpinum. Bioorg. Med. Chem. Lett. 19: 2801-2803. https://doi.org/10.1016/j.bmcl.2009.03.108
- Hong, J. H., Lee, M. S., Bae, E. Y., Kim, Y. H., Oh, H. C., Oh, W. K., Kim, B. Y. and Ahn, J. S. (2004) Screening of the inhibitory activity of medicinal plants against protein tyrosine phosphatase 1B. Kor. J. Pharmacogn. 35: 16-21.
- Kim, J. S., Kim, H. and Ko, J. H. (2002) Studies on the processing of herbal medicines (III)-HPLC analysis of magnolol and inhibitory effects on the Formation of advanced glycation endproducts (AGEs) in vitro of unprocessed and processed Magnolia Bark. Kor. J. Pharmacogn. 33: 308-311.
- Lee,Y. M., Kim, C. S., Kim, Y. S., Sohn, E. J. and Kim, J. S. (2006) Effects of magnolol on the AGEs formation and sorbitol accumulation in STZ-induced diabetic rats. American Diabetes Association's 66th Scientific Sessions, p. A120.
- Sohn, E. J., Kim, C. S., Kim, Y. S., Jung, D. H., Jang, D. S., Lee, Y. M. and Kim, J. S. (2007) Effects of magnolol (5,5'- diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats. Life Sci. 80: 468-475. https://doi.org/10.1016/j.lfs.2006.09.037
- Yoshida, T., Sakane, N., Wakabayashi, Y., Umekawa, T. and Kondo, M. (1995) Thermogenic, anti-obesity effects of bofutsusho- san in MSG-obese mice. Int. J. Obes. Relat. Metab. Disord. 19: 717-722.
- Liu, I. M., Hsu, F. L., Chen, C. F. and Cheng, J. T. (2000) Antihyperglycemic action of isoferulic acid in streptozotocininduced diabetic rats. Br. J. Pharmacol. 129: 631-636. https://doi.org/10.1038/sj.bjp.0703082
- Liu, I. M., Chi, T. C., Hsu, F. L., Chen, C. F. and Cheng, J. T. (1999) Isoferulic acid as active principle from the rhizoma of Cimicifuga dahurica to lower plasma glucose in diabetic rats. Planta Med. 65: 712-714. https://doi.org/10.1055/s-1999-14048